Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
WO 2024023766
POLYTHÉRAPIE À BASE D'INHIBITEUR DE P13K
granted -
CA 3259243
POLYTHÉRAPIE ANTICANCÉREUSE COMPRENANT UN INHIBITEUR DE BCL-2
granted -
CA 3263005
POLYPEPTIDES SE LIANT À UN ÉPITOPE SPÉCIFIQUE DU RÉCEPTEUR FC NÉONATAL
granted -
CA 3259252
POLYTHÉRAPIE ANTICANCÉREUSE COMPRENANT UN INHIBITEUR DE FLT3
granted -
CA 3256289
MÉTHODES PERMETTANT DE FAVORISER LA CROISSANCE DE RATTRAPAGE SAINE
granted -
US 11883420
Sting agonists for treating bladder cancer and solid tumors
granted -
US 11884736
Antibodies which bind to glucagon-like peptide 1 receptor (GLP1R)
granted -
US 11883381
ASH1L inhibitors and methods of treatment therewith
granted -
US 11883386
Prolyl hydroxylase inhibitors and methods of use
granted -
US 11884731
Vedolizumab for the treatment of fistulizing Crohn's disease
granted -
US 11883223
Hepatic inflammation analysis with dynamic PET
granted -
US 11884707
Compositions for detection, inhibition and imaging of indoleamine 2, 3-dioxygenase 1 (IDO1) and methods of making and using same
granted -
US 11884647
Compounds and methods for targeting pathogenic blood vessels
granted -
US 11883535
Liposomal particles, methods of making same and uses thereof
granted -
US 11883432
Chimeric antigen receptor system with adaptable receptor specificity
granted -
US 11884657
PI-kinase inhibitors with anti-infective activity
granted -
US 11883441
Compositions and methods for inhibiting seizures
granted -
US 11884656
Pyrrole derivatives as PLK1 inhibitors
granted -
US 11883431
T-cells modified to overexpress PHF19
granted -
US 11883433
Chimeric antigen receptor comprising anti-mesothelin scFv, and use thereof
granted -
US 11884715
Activin receptor type IIB variants and methods of use thereof
granted -
US 11885817
Biomarkers and methods for detection of seizures and epilepsy
granted -
US 11883383
Pharmaceutically acceptable salts of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine
granted -
US 11884944
Fusion proteins comprising sulfoglucosamine sulfohydrolase enzymes and methods thereof
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.